Peterlabs Holdings Bhd (XKLS:0171) Debt-to-Equity : 0.24 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Peterlabs Holdings Bhd Debt-to-Equity?

Peterlabs Holdings Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM16.6 Mil. Peterlabs Holdings Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM2.2 Mil. Peterlabs Holdings Bhd's Total Stockholders Equity for the quarter that ended in Mar. 2024 was RM77.5 Mil. Peterlabs Holdings Bhd's debt to equity for the quarter that ended in Mar. 2024 was 0.24.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Peterlabs Holdings Bhd's Debt-to-Equity or its related term are showing as below:

XKLS:0171' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09 Med: 0.23 Max: 0.44
Current: 0.24

During the past 13 years, the highest Debt-to-Equity Ratio of Peterlabs Holdings Bhd was 0.44. The lowest was 0.09. And the median was 0.23.

XKLS:0171's Debt-to-Equity is ranked better than
56.09% of 845 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs XKLS:0171: 0.24

Peterlabs Holdings Bhd Debt-to-Equity Historical Data

The historical data trend for Peterlabs Holdings Bhd's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peterlabs Holdings Bhd Debt-to-Equity Chart

Peterlabs Holdings Bhd Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.16

0.09

0.27

0.17

0.28

Peterlabs Holdings Bhd Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.23	0.23	0.24	0.28	0.24

Competitive Comparison of Peterlabs Holdings Bhd's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Peterlabs Holdings Bhd's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's Debt-to-Equity falls into.

Peterlabs Holdings Bhd Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Peterlabs Holdings Bhd's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(19.429	+	2.274)	/	77.816
	=	0.28

Peterlabs Holdings Bhd's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(16.556	+	2.201)	/	77.541
	=	0.24

Peterlabs Holdings Bhd (XKLS:0171) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Peterlabs Holdings Bhd Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Peterlabs Holdings Bhd's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Peterlabs Holdings Bhd (XKLS:0171) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Peterlabs Holdings Bhd (XKLS:0171) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800

Website

https://www.peterlabs.com.my

Peterlabs Holdings Bhd is a Malaysia based company engaged in manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis and feed formulation. The operating segments of the group are Manufacturing which relates to manufacturing of animal health and nutrition products, and Trading which relates to trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplement, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally, and generates key revenue from the Trading segment.

Peterlabs Holdings Bhd (XKLS:0171) Headlines

No Headlines